Receive News & Ratings for Genesco Inc. Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Zacks: Brokerages Expect Genesco Inc. (GCO) Will Announce Quarterly Sales of $633.27 Million

Equities analysts forecast that Genesco Inc. (NYSE:GCO) will announce sales of $633.27 million for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Genesco’s earnings, with estimates ranging from $619.50 million to $649.30 million. Genesco posted sales of $625.56 million during the same quarter last year, which would suggest a positive year over year growth rate of 1.2%. The firm is scheduled to announce its next quarterly earnings report before the market opens on Thursday, August 31st.

Receive News & Ratings for Genesco Inc. Daily

Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

On average, analysts expect that Genesco will report full-year sales of $633.27 million for the current fiscal year, with estimates ranging from $2.90 billion to $2.92 billion. For the next financial year, analysts anticipate that the business will report sales of $2.96 billion per share, with estimates ranging from $2.95 billion to $2.97 billion. Zacks’ sales averages are a mean average based on a survey of research analysts that that provide coverage for Genesco.

Genesco (NYSE:GCO) last posted its quarterly earnings results on Thursday, May 25th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.28 by $0.22. Genesco had a return on equity of 8.41% and a net margin of 3.07%. The company had revenue of $643.40 million for the quarter, compared to the consensus estimate of $644.15 million. During the same quarter in the previous year, the business earned $0.62 earnings per share. Genesco’s revenue was down .8% compared to the same quarter last year.

Several brokerages recently weighed in on GCO. Zacks Investment Research upgraded shares of Genesco from a “strong sell” rating to a “hold” rating in a research report on Tuesday, August 1st. BidaskClub upgraded shares of Genesco from a “strong sell” rating to a “sell” rating in a research report on Monday, July 31st. Jefferies Group LLC restated a “hold” rating and set a $48.00 price target on shares of Genesco in a research report on Friday, July 14th. ValuEngine upgraded shares of Genesco from a “hold” rating to a “buy” rating in a research report on Thursday, July 13th. Finally, Piper Jaffray Companies set a $39.00 price target on shares of Genesco and gave the stock a “buy” rating in a research report on Saturday, June 24th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $48.29.

In related news, Director Kevin Patrick Mcdermott acquired 1,340 shares of the stock in a transaction that occurred on Thursday, June 1st. The shares were purchased at an average cost of $37.18 per share, with a total value of $49,821.20. Following the completion of the transaction, the director now owns 5,192 shares of the company’s stock, valued at approximately $193,038.56. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Company insiders own 3.30% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. increased its stake in Genesco by 45,756.3% in the first quarter. BlackRock Inc. now owns 2,482,203 shares of the company’s stock valued at $137,638,000 after buying an additional 2,476,790 shares in the last quarter. Eagle Asset Management Inc. increased its stake in Genesco by 9.4% in the second quarter. Eagle Asset Management Inc. now owns 2,064,808 shares of the company’s stock valued at $69,996,000 after buying an additional 177,335 shares in the last quarter. Vanguard Group Inc. increased its stake in Genesco by 0.8% in the first quarter. Vanguard Group Inc. now owns 1,964,020 shares of the company’s stock valued at $108,905,000 after buying an additional 15,003 shares in the last quarter. Royce & Associates LP increased its stake in Genesco by 1.2% in the first quarter. Royce & Associates LP now owns 659,510 shares of the company’s stock valued at $36,570,000 after buying an additional 7,500 shares in the last quarter. Finally, Victory Capital Management Inc. increased its stake in Genesco by 59.2% in the second quarter. Victory Capital Management Inc. now owns 647,015 shares of the company’s stock valued at $21,934,000 after buying an additional 240,722 shares in the last quarter.

WARNING: “[[title]]” was reported by [[site]] and is the sole property of of [[site]]. If you are reading this article on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The correct version of this article can be viewed at [[permalink]].

Genesco (NYSE:GCO) traded up 0.88% on Thursday, hitting $28.70. The stock had a trading volume of 342,689 shares. Genesco has a 1-year low of $27.75 and a 1-year high of $74.21. The firm has a market capitalization of $562.32 million, a price-to-earnings ratio of 6.45 and a beta of 1.24. The stock’s 50-day moving average is $32.07 and its 200 day moving average is $46.89.

Genesco Company Profile

Genesco Inc is a retailer and wholesaler of footwear, apparel and accessories. The Company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group and Licensed Brands. It relies on independent third-party manufacturers for production of its footwear products sold at wholesale.

Get a free copy of the Zacks research report on Genesco (GCO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com